Expanding Contraceptive Choice: Webinar on Tubal Ligation
December 06, 2018
Some 214 million women of reproductive age in developing regions who want to avoid pregnancy are not using a modern contraceptive method. Evidence suggests that expanding method choice, as well as providing better information about available methods, can improve family planning access for these girls and women.
The sixth webinar in this series: Tubal Ligation, was on Thursday, December 6, 2018, from 9:00–10:00 a.m. EDT.
Kavita Nanda of FHI 360; Mark Barone of Population Council; and Japheth Ominde of EngenderHealth, discussed tubal ligation and their in-country and programmatic experiences.
Ominde Japhet Achola is a Regional Clinical Quality Advisor, at EngenderHealth. He is based at the EngenderHealth Office in Nairobi. He is an Obstetric/Gynecologist by background. Over the last 34 years, he has worked in the field of health particularly reproductive health. During this period, he worked with the public sector in Kenya, regional quasi-governmental bodies and international non-governmental organizations and several other International NGOs.
Dr. Kavita Nanda is Director of Medical Research in the Contraceptive Technology Innovation Department at FHI 360. Her specific expertise is in contraception, both in contraceptive development and the intersection of contraception with HIV. Over the past 20 years she has designed and implemented regulatory-compliant, high quality clinical research to either bring new contraceptive products to market or improve the use of existing methods.
Mark A. Barone, DVM, MS, recently joined the Population Council as a Senior Scientist in their Center for Biomedical Research in New York City. Prior to that, he had spent nearly 25 years at EngenderHealth where he worked on research, technology introduction, and management of health programs related primarily to contraception, HIV, female genital fistula, and cervical cancer. Dr. Barone has broad expertise in clinical, epidemiological and implementation science research, and has wide-ranging experience in research on, and introduction of, new technologies and approaches for health, working in partnership with government agencies, the private sector, universities, and non-for-profits around the world. Most recently, he has been the principal investigator on a series of clinical trials exploring ways to simplify voluntary medical male circumcision services for HIV prevention in Africa, and a large randomized controlled trial of task shifting tubal ligation services to non-physicians in Tanzania. Dr. Barone holds a Doctor of Veterinary Medicine degree and a Master of Science degree in reproductive physiology from Colorado State University.
Some 214 million women of reproductive age in developing regions who want to avoid pregnancy are not using a modern contraceptive method. Evidence suggests that expanding method choice, as well as providing better information about available methods, can improve family planning access for these girls and women.
The Advancing Partners & Communities project, in collaboration with Family Planning 2020, the Implementing Best Practices initiative, and USAID's Office of Population and Reproductive Health, hosted a webinar series to share information about various family planning methods.
The sixth webinar in this series: Tubal Ligation, was on Thursday, December 6, 2018, from 9:00–10:00 a.m. EDT.
Kavita Nanda of FHI 360; Mark Barone of Population Council; and Japheth Ominde of EngenderHealth, discussed tubal ligation and their in-country and programmatic experiences.
Meet the Speakers
Ominde Japhet Achola
Ominde Japhet Achola is a Regional Clinical Quality Advisor, at EngenderHealth. He is based at the EngenderHealth Office in Nairobi. He is an Obstetric/Gynecologist by background. Over the last 34 years, he has worked in the field of health particularly reproductive health. During this period, he worked with the public sector in Kenya, regional quasi-governmental bodies and international non-governmental organizations and several other International NGOs.
Dr. Kavita Nanda
Dr. Kavita Nanda is Director of Medical Research in the Contraceptive Technology Innovation Department at FHI 360. Her specific expertise is in contraception, both in contraceptive development and the intersection of contraception with HIV. Over the past 20 years she has designed and implemented regulatory-compliant, high quality clinical research to either bring new contraceptive products to market or improve the use of existing methods.
Mark A. Barone
Mark A. Barone, DVM, MS, recently joined the Population Council as a Senior Scientist in their Center for Biomedical Research in New York City. Prior to that, he had spent nearly 25 years at EngenderHealth where he worked on research, technology introduction, and management of health programs related primarily to contraception, HIV, female genital fistula, and cervical cancer. Dr. Barone has broad expertise in clinical, epidemiological and implementation science research, and has wide-ranging experience in research on, and introduction of, new technologies and approaches for health, working in partnership with government agencies, the private sector, universities, and non-for-profits around the world. Most recently, he has been the principal investigator on a series of clinical trials exploring ways to simplify voluntary medical male circumcision services for HIV prevention in Africa, and a large randomized controlled trial of task shifting tubal ligation services to non-physicians in Tanzania. Dr. Barone holds a Doctor of Veterinary Medicine degree and a Master of Science degree in reproductive physiology from Colorado State University.
View recordings from the five previous webinars in the Expanding Contraceptive Choice series: